The effect of ursodeoxycholic acid for treatment of large and multiple common bile duct stones
Not Applicable
Recruiting
- Conditions
- CBD stones.Calculus of gallbladder with acute cholecystitis
- Registration Number
- IRCT20161205031252N8
- Lead Sponsor
- Ghoum University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 64
Inclusion Criteria
Common bile duct stone with a diameter greater than 15 mm
More than 3 stones in common bile duct
Exclusion Criteria
History of recent surgery on bile ducts
History of gasterectomy
History of duodenal stricture
Patients who do not fill the informed concept form
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Common bile duct clearing. Timepoint: 2 months after CBD stenting. Method of measurement: By endoscopic retrograde cholangiopancreatography.
- Secondary Outcome Measures
Name Time Method Chollangitis. Timepoint: After endoscopic retrograde cholangiopancreatography. Method of measurement: According to Charcot's triad including abdominal pain, serum bilirubin measurement and core body temperature measurement.;Pancreatitis. Timepoint: After endoscopic retrograde cholangiopancreatography. Method of measurement: Serum amylase level measurement.;Reduction in stones size. Timepoint: Two months after common bile duct stenting. Method of measurement: By fluoroscopy during endoscopic retrograde cholangiopancreatography.;Reduction in common bile duct (CBD) stone number. Timepoint: Two months after CBD stenting. Method of measurement: By endoscopic retrograde cholangiopancreatography.